Corvia Medical

COMPANY INFORMATION:

Corvia Medical is revolutionizing the treatment of heart failure (HF) through novel transcatheter cardiovascular devices. Founded in 2009 and headquartered in Tewksbury, MA, Corvia Medical is dedicated to transforming the standard of care for HF treatment, enabling patients to reclaim their lives. To learn more, please visit corviamedical.com.

PRODUCTS:

The Corvia® Atrial Shunt is an investigational, minimally invasive cardiac implant designed to reduce HF symptoms by decreasing left atrial pressure. The shunt was granted FDA Breakthrough Device designation in 2019 and is currently the subject of the RESPONDER-HF confirmatory trial.

Learn more: Corvia Atrial Shunt Overview and Corvia Atrial Shunt Animation

Caution: In the United States, the Corvia® Atrial Shunt System is an investigational device, limited by United States law to investigational use.